WAME Manuscript Checklist
Please consult the WAME explanatory document at: https://wame.org/manuscript-submission-checklist
Translation into English.
1. Prior Publication
Has the manuscript been previously published (in this form or in another form with significant similarity or overlap)? There are situations in which this may be acceptable; for example, most journals do not consider preprints or theses/dissertations as prior publications (see ICMJE for a discussion on overlapping publications). Is the manuscript under consideration elsewhere? (See ICMJE for a discussion on duplicate submission).
Check all that apply:
☐ No
☐ Yes, prior publication: provide the link, citation, or other specific details:
☐ Yes, under consideration elsewhere: provide specific details:
2. Funding and Sponsorship (See ICMJE for recommendations on reporting)
a. Did the research or the authors receive funding or sponsorship?
☐ No
☐ Yes: provide the specific grant numbers, the initials of the authors who received each funding award, the full names of the commercial companies or other entities that funded the study or the authors, the initials of the authors who received salaries or other types of funding from commercial companies or other entities, and the URLs of the sponsors' websites:
b. Did any funder or sponsor have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript?
☐ No
☐ Yes: specify below what role they had:
c. The Funding section of the manuscript includes all the information you provided above.
☐ Yes
☐ No. Explain why not below:
3. Authorship
All named authors meet the journal's authorship criteria, and all individuals who meet those criteria are named as authors (see the WAME authorship statement for more information).
☐ Yes
☐ No. Explain below:
4. Use of Artificial Intelligence (AI) and Large Language Models
Was an AI-based system used for any part of the work? (See WAME and ICMJE recommendations).
☐ No
☐ Yes: complete the following information:
a. Which AI-based systems were used?
b. Which parts of the work included the use of AI? Indicate each part and what the AI was specifically used for, including use in: research; editorial work (writing, editing, translation); references; design (creation of tables, figures, graphs, and photographs); and searching, classifying, analyzing, or conducting bibliographic studies.
c. Did the authors review and correct the results and texts generated by the AI?
☐ No
☐ Yes: what changes were made to the results?
d. Were all claims and references compiled by the AI-based system independently verified to ensure their accuracy?
☐ Yes
☐ No
e. The following information is included in the manuscript:
☐ The abstract (if applicable) summarizes which parts included the use of AI.
☐ For a research manuscript: the Methods describe the ways in which AI was used in the study, including:
1. The queries that were used and the specific dates on which those queries were made.
2. The AI system used to answer the questions.
3. The parts of the research or manuscript affected, including research components, text, tables, figures, appendices, supplementary material, etc.
4. If AI was used in studies involving human subjects, how participants were informed about its use and how privacy or anonymity was preserved.
☐ For a non-research manuscript: the manuscript includes:
1. The queries that were used and the specific dates on which those queries were made.
2. The AI system used to answer the questions.
3. The parts of the manuscript affected, including text, tables, figures, appendices, supplementary material, etc.
☐ Yes
☐ No. Provide the information here or in an attached file:
*Authors of non-research manuscripts may go directly to the end of the form to complete item 10.*
RESEARCH MANUSCRIPTS
5. Trial Registration
Has the study been registered in a clinical trial database included in the WHO International Clinical Trials Registry Platform (https://www.who.int/clinical-trials-registry-platform)? (See ICMJE for requirements and justification).
☐ Yes: provide the database and trial registration number:
☐ No. Explain below:
6. Research Ethics (See also the Declaration of Helsinki and the ARRIVE guidelines [Animal Research: Reporting of In Vivo Experiments])
a. Was the research approved by a local, regional, or national independent review board and/or animal ethics committee?
☐ Yes. Provide the name of the committee and institution:
☐ No. Explain why not:
b. Did the human participants provide informed consent, either written or oral?
☐ Yes, written consent.
☐ Yes, oral consent. Explain why consent was oral rather than written:
☐ No consent was obtained. Explain why not:
☐ Animal research only.
7. Study Protocol (See ICMJE recommendations regarding protocol review)
a. Has the study protocol been published or made publicly available?
☐ Yes: provide the citation and link:
☐ No. Please provide the study protocol as an attached file.
b. Are the differences between the protocol and the manuscript explained in the manuscript?
☐ Yes
☐ No. Explain the differences here or in an attached file:
8. Data Access (Required for clinical trials by ICMJE; ICMJE also provides specific information to be included in manuscripts)
a. Will the authors provide to the journal any data and software code supporting the work, if requested by the journal?
☐ Yes
☐ No. Explain why not:
b. Are the data underlying the study available for access?
☐ Yes, the data are publicly available: provide access information and the URL:
☐ Yes, the data are available upon request: who will provide access upon request and under what conditions?
☐ No. Explain why not:
9. Research Reporting
Was a research reporting tool (e.g., CONSORT from the EQUATOR network) used during the study or the writing of the manuscript? (See ICMJE recommendations).
☐ Yes: specify the research reporting tool used and provide the completed checklist with the submission:
☐ No
10. Corresponding Author Declaration
I, the corresponding author, certify that the information provided above is correct and complete.
11. Corresponding Author Signature
WAME (2023), Creative Commons CC BY 4.0
